For the Inventor, By the Inventor

Enter assignee name

Breda, Netherlands

Cibus Europe, B.v.

Calculating rank

USPTO Granted Patents = 15

CIPO Patents = 2

EPO Patents = 19

Forward Citations = 14

Loading Chart...

Loading Chart...

15 inventors (with patents filed for the assignee):

Gregory F W Gocal (13 out of 13 patents)

Peter R Beetham (12 out of 25 patents)

James Pearce (10 out of 11 patents)

4. Christian Schopke (10 out of 10 patents)

5. Noel Sauer (8 out of 8 patents)

6. Rosa E Segami (8 out of 8 patents)

7. Jerry Mozoruk (8 out of 8 patents)

8. Keith A Walker (4 out of 15 patents)

9. Sarah Dumm (2 out of 2 patents)

10. Uvini Gunawardena (2 out of 9 patents)

11. Gregory FW Gocal (2 out of 2 patents)

12. Aura Estela Gonzalez Schopke (2 out of 2 patents)

13. Tracey A Lincoln (1 out of 1 patent)

14. Mark E Knuth (1 out of 25 patents)

15. Patricia L Avissar (4 patents)

15 patents: Sort by Forward Citations

1. 12570993 - MUTATED PROTOPORPHYRINOGEN IX OXIDASE (PPX) GENES (2026-03-10),

2. 12559763 - FAD2 GENES AND MUTATIONS (2026-02-24),

3. 12331303 - Methods and compositions for increasing efficiency of targeted gene modification using oligonucleotide-mediated gene repair (2025-06-17),

4. 11761011 - Methods and compositions for increasing efficiency of targeted gene modification using oligonucleotide-mediated gene repair (2023-09-19),

5. 11542515 - Methods and compositions for increasing efficiency of targeted gene modification using oligonucleotide-mediated gene repair (2023-01-03),

6. 11434494 - Targeted gene modification using oligonucleotide-mediated gene repair (2022-09-06),

7. 11421240 - Methods and compositions for increasing efficiency of targeted gene modification using oligonucleotide-mediated gene repair (2022-08-23),

8. 11359208 - Shatterproof genes and mutations (2022-06-14),

9. 11111500 - Mutated protoporphyrinogen IX oxidase (PPX) genes (2021-09-07),

10. 10954522 - Methods and compositions for increasing efficiency of targeted gene modification using oligonucleotide-mediated gene repair (2021-03-23),

11. 10815495 - Mutated allene oxide synthase 2 (AOS2) genes (2020-10-27),

12. 10676755 - Mutated acetohydroxyacid synthase genes in euphorbiaceae and plant material comprising such genes (2020-06-09),

13. 10287594 - Methods and compositions for increasing efficiency of targeted gene modification using oligonucleotide-mediated gene repair (2019-05-14),

14. 9957515 - Methods and compositions for targeted gene modification (2018-05-01),

15. 9790515 - Mutated allene oxide synthase 2 (AOS2) genes (2017-10-17),

Company Overview

Cibus Europe, B.V. is a prominent player in the agricultural biotechnology sector, specializing in the development of innovative crop protection solutions. The company focuses on harnessing advanced genetic technologies to enhance plant resilience and productivity, catering to the evolving needs of farmers and the agricultural industry. Based in Breda, Netherlands, Cibus is dedicated to sustainable agricultural practices, aiming to improve food security while minimizing environmental impact through its cutting-edge research and development initiatives.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

15 Patents

#5 in

#464 in

#39,972 in the World

Breda, Netherlands

Cibus Europe, B.v.

Forward Citations = 14

15 inventors:

Gregory F W Gocal (13 out of 13 patents)

Peter R Beetham (12 out of 25 patents)

James Pearce (10 out of 11 patents)

4. Christian Schopke (10 out of 10 patents)

5. Noel Sauer (8 out of 8 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cibus Europe, B.v.. Retrieved from https://idiyas.com/company/cibus-europe-b-v

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…